BusinessTelix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public OfferingBy Nasdaq OMXNov 8, 2017, 11:20 PM UTC
BusinessTelix Pharmaceuticals Limited Launches $50 Million Underwritten Initial Public Offering (ASX: TLX)By Nasdaq OMXOct 23, 2017, 9:00 PM UTC